✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine

5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine

CAS 738-70-5C14H18N4O3MW 290.32

5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine (CAS 738-70-5) — formula C14H18N4O3, molecular weight 290.32; category organic chemicals.

Product Overview

CAS Number738-70-5
Molecular FormulaC14H18N4O3
Molecular Weight290.32
Melting Point390 to 397 °F (NTP, 1992)
LogP0.91
ApplicationsUses: Veterinary antimicrobial agent, Has a broad spectrum of antimicrobial activity and extends the spectrum of sulfamethoxazole to include many urinary and systemic pathogens untreatable by this sulfa drug alone., MEDICATION (VET), MEDICATION, Use (kg) in Switzerland (2009): >250, Use (kg, approx.) in Germany (2009): ?7500, exact) in Germany (2009): 7475, Use (kg) in USA (2002): 463, Use (kg) in France (2004): 3346, Consumption (g per capita) in Switzerland (2009): 0.032, Consumption (g per capita, approx.) in Germany (2009): 0.092, exact) in Germany (2009): 0.091, Consumption (g per capita) in the USA (2002): 0.0016, Consumption (g per capita) in France (2004): 0.055, Excretion rate: 0.6, Calculated removal (%): 8.8, Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients, Pharmaceuticals -> Animal Drugs -> Approved in Taiwan, Methods of Manufacturing: Prepn from guanidine and beta-ethoxy-3, 4, 5-trimethoxybenzylbenzalnitrile, Trimethoprim, is a, drug that, is, made from vanillin., Formulations, Preparations: Preparations: Tablets, 100 and 200 mg., Component of Bactrin and Septra, General Manufacturing Information: See sulfamethoxazole, sulfadiazine, sulfametrole, sulfamoxole, and sulfalene for list of trade names of mixtures with trimethoprim., Authorized or allowed for use in aquaculture in certain European countries., Solid phase reactions between trimethoprim & sulfamethoxazole were investigated by IR spectrometry & differential scanning calorimetry in 4 tablet formulations. Heating & humidity were found to enhance the conditions for reactions, with the most likely manufacturing step causing reactions being wet granulation. Mixing, grinding & compression of powders caused no interactions.
CategoryOrganic Chemicals

Applications

Documented applications: Uses: Veterinary antimicrobial agent, Has a broad spectrum of antimicrobial activity and extends the spectrum of sulfamethoxazole to include many urinary and systemic pathogens untreatable by this sulfa drug alone., MEDICATION (VET), MEDICATION, Use (kg) in Switzerland (2009): >250, Use (kg, approx.) in Germany (2009): ?7500, exact) in Germany (2009): 7475, Use (kg) in USA (2002): 463, Use (kg) in France (2004): 3346, Consumption (g per capita) in Switzerland (2009): 0.032, Consumption (g per capita, approx.) in Germany (2009): 0.092, exact) in Germany (2009): 0.091, Consumption (g per capita) in the USA (2002): 0.0016, Consumption (g per capita) in France (2004): 0.055, Excretion rate: 0.6, Calculated removal (%): 8.8, Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients, Pharmaceuticals -> Animal Drugs -> Approved in Taiwan, Methods of Manufacturing: Prepn from guanidine and beta-ethoxy-3, 4, 5-trimethoxybenzylbenzalnitrile, Trimethoprim, is a, drug that, is, made from vanillin., Formulations, Preparations: Preparations: Tablets, 100 and 200 mg., Component of Bactrin and Septra, General Manufacturing Information: See sulfamethoxazole, sulfadiazine, sulfametrole, sulfamoxole, and sulfalene for list of trade names of mixtures with trimethoprim., Authorized or allowed for use in aquaculture in certain European countries., Solid phase reactions between trimethoprim & sulfamethoxazole were investigated by IR spectrometry & differential scanning calorimetry in 4 tablet formulations. Heating & humidity were found to enhance the conditions for reactions, with the most likely manufacturing step causing reactions being wet granulation. Mixing, grinding & compression of powders caused no interactions..

Technical Profile

What this product is

5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine is a carbon-based organic compound with CAS registry number 738-70-5 and molecular formula C14H18N4O3 (molecular weight 290.32), belonging to the organic chemicals segment of chemical raw materials.

Identification

CAS number: 738-70-5

Its molecular formula C14H18N4O3 comprises 14 C, 18 H, 4 N, 3 O atoms.

Also known as: 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine · 5-((3,4,5-三甲氧基苯基)甲基)-2,4-嘧啶二胺

Category: organic chemicals

Frequently Asked Questions

What is the CAS number of 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine?

The CAS registry number of 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine is 738-70-5.

What is the molecular formula and molecular weight of 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine?

Molecular formula C14H18N4O3, molecular weight 290.32.

What other names is 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine known by?

It is also registered under: 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine, 5-((3,4,5-三甲氧基苯基)甲基)-2,4-嘧啶二胺.

What are the documented applications of 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine?

Recorded applications: Uses: Veterinary antimicrobial agent, Has a broad spectrum of antimicrobial activity and extends the spectrum of sulfamethoxazole to include many urinary and systemic pathogens untreatable by this sulfa drug alone., MEDICATION (VET), MEDICATION, Use (kg) in Switzerland (2009): >250, Use (kg, approx.) in Germany (2009): ?7500, exact) in Germany (2009): 7475, Use (kg) in USA (2002): 463, Use (kg) in France (2004): 3346, Consumption (g per capita) in Switzerland (2009): 0.032, Consumption (g per capita, approx.) in Germany (2009): 0.092, exact) in Germany (2009): 0.091, Consumption (g per capita) in the USA (2002): 0.0016, Consumption (g per capita) in France (2004): 0.055, Excretion rate: 0.6, Calculated removal (%): 8.8, Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients, Pharmaceuticals -> Animal Drugs -> Approved in Taiwan, Methods of Manufacturing: Prepn from guanidine and beta-ethoxy-3, 4, 5-trimethoxybenzylbenzalnitrile, Trimethoprim, is a, drug that, is, made from vanillin., Formulations, Preparations: Preparations: Tablets, 100 and 200 mg., Component of Bactrin and Septra, General Manufacturing Information: See sulfamethoxazole, sulfadiazine, sulfametrole, sulfamoxole, and sulfalene for list of trade names of mixtures with trimethoprim., Authorized or allowed for use in aquaculture in certain European countries., Solid phase reactions between trimethoprim & sulfamethoxazole were investigated by IR spectrometry & differential scanning calorimetry in 4 tablet formulations. Heating & humidity were found to enhance the conditions for reactions, with the most likely manufacturing step causing reactions being wet granulation. Mixing, grinding & compression of powders caused no interactions..

Which category does 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine belong to?

Category: Organic Chemicals.

PubChem Public Data

Independent reference data for 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine (CAS 738-70-5), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number738-70-5
PubChem CID5578
Molecular formulaC14H18N4O3
IUPAC name5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
UNII (FDA)AN164J8Y0X

Computed descriptors

Molecular Weight290.32
XLogP30.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass290.13789045
Monoisotopic Mass290.13789045
Topological Polar Surface Area106
Heavy Atom Count21

Physicochemical values on record

Melting Point390 to 397 °F (NTP, 1992)
Melting Point199-203 °C
Melting Point199 - 203 °C
Solubility400
SolubilityIn water, 400 mg/l @ 25 °C
Solubility6.15e-01 g/L
LogP0.91
LogPlog Kow = 0.91
LogP0.6
LogP0.92

Documented uses on record

    Has a broad spectrum of antimicrobial activity and extends the spectrum of sulfamethoxazole to include many urinary and systemic pathogens untreatable by this sulfa drug alone.Use (kg) in Switzerland (2009): >250

    Synonyms and trade names

    trimethoprim; 738-70-5; Proloprim; Trimpex; 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine; Trimetoprim; Monotrim; Trimopan; Wellcoprim; Syraprim; Monoprim; Uretrim; Trimethoprime; Trimethoprimum; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine; Trimetoprima

    Regulatory listings held on file

    GHS notification summary7.9% (11 / 140)

    GHS hazard classification

    GHS notification summary7.9% (11 / 140)
    Reported hazard statementsH302 (85%), H361 (30.7%), H372 (26.4%), H411 (26.4%), H301, H360, H362, H373

    This chemical does not meet GHS hazard criteria for 7.9% (11 of 140) of reports.

    H302 (85%): Harmful if swallowed [Warning Acute toxicity, oral]

    What the public record says

    5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine · CAS 738-70-5 · C14H18N4O3. UNII AN164J8Y0X. Melting Point: 390 to 397 °F (NTP, 1992); Melting Point: 199-203 °C; Melting Point: 199 - 203 °C.

    Physical description and handling notes

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 5-((3,4,5-三甲氧基苯基)甲基)-2,4-嘧啶二胺

鲁ICP备19031700号-2